Smurfit backs cancer biotech firm

Inflection Biotech recently raised €230,000 from investors to develop targeted therapies to tackle several cancers

Barry J Whyte

Chief Feature Writer @whytebarry
13th December, 2020
Smurfit backs cancer biotech firm
Michael Smurfit: €80k investment in biotech firm

Michael Smurfit, the former chief executive of Smurfit Kappa, has put just over €80,000 into a biotech start-up aiming to develop targeted cancer treatments.

Documents filed for Inflection Biotech show that the company raised just under €230,000 in recent months, with Smurfit buying around €81,000 worth of shares through his Isle of Man-based vehicle, Bacchantes.

Smurfit was joined in the investment by Conor Mallaghan, whose family owns the Carton House golf resort. Mallaghan is also...

Subscribe from just €1 for the first month!


What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

Paul McCann to join Ergo as chief executive

Virtual IDA trade mission seeks to create opportunities for SMEs